Orthofix International N.V. (NASDAQ:OFIX) released its quarterly earnings results on Monday. The medical device company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01, Bloomberg Earnings reports. Orthofix International N.V. had a negative net margin of 0.82% and a positive return on equity of 10.03%. The firm had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. During the same period in the previous year, the company earned $0.41 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Orthofix International N.V. updated its FY17 guidance to $1.54-1.60 EPS.

Shares of Orthofix International N.V. (OFIX) opened at 44.85 on Tuesday. Orthofix International N.V. has a 52-week low of $32.51 and a 52-week high of $47.18. The firm’s 50-day moving average is $45.55 and its 200 day moving average is $40.42. The stock’s market cap is $809.27 million.

Hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Orthofix International N.V. by 18.6% in the first quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock worth $69,278,000 after buying an additional 284,482 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Orthofix International N.V. by 2.7% in the first quarter. Dimensional Fund Advisors LP now owns 779,771 shares of the medical device company’s stock worth $29,748,000 after buying an additional 20,473 shares during the last quarter. Wellington Management Group LLP acquired a new position in shares of Orthofix International N.V. during the first quarter worth approximately $20,021,000. Oakview Capital Management L.P. boosted its position in shares of Orthofix International N.V. by 2.9% in the first quarter. Oakview Capital Management L.P. now owns 510,699 shares of the medical device company’s stock worth $19,483,000 after buying an additional 14,491 shares during the last quarter. Finally, State Street Corp boosted its position in shares of Orthofix International N.V. by 27.0% in the first quarter. State Street Corp now owns 462,479 shares of the medical device company’s stock worth $17,640,000 after buying an additional 98,212 shares during the last quarter. 99.68% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/08/orthofix-international-n-v-nasdaqofix-posts-earnings-results-beats-estimates-by-0-01-eps.html.

A number of equities analysts recently commented on OFIX shares. Zacks Investment Research cut shares of Orthofix International N.V. from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. Ladenburg Thalmann Financial Services started coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. They set a “buy” rating and a $53.25 price target for the company. SunTrust Banks, Inc. started coverage on shares of Orthofix International N.V. in a research note on Tuesday, May 23rd. They set a “buy” rating and a $49.00 price target for the company. BidaskClub cut shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Finally, BTIG Research started coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 21st. They set a “buy” rating and a $52.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $51.88.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.